about
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin huma...
Read More
5.74
0.00
(0.00%)
97,281
XNAS Volume
High vol.+gain this week
XNAS 03 Sep, 2025 9:20 AM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Mannkind Corp Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..